Kronox Lab Sciences Limited Stock Price Today (NSE: KRONOX)

Kronox Lab Sciences Limited

172.790.78 (0.45%)
Market Closed

Fundamental Score

...

Kronox Lab Sciences Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Kronox Lab Sciences Limited share price today is 172.79, down 0.45% on NSE/BSE as of 18 September 2026. Kronox Lab Sciences Limited (KRONOX) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of 641.12 (Cr). The 52-week high for KRONOX share price is 223.42 and the 52-week low is 96.00. At a P/E ratio of 22.18x, KRONOX is currently trading below its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 26.82% and a debt-to-equity ratio of 0.01.

Kronox Lab Sciences Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
223.42
Low
144.41
Volume
17.3L
Change
+4.33%

Kronox Lab Sciences Limited share price chart: 4.33% return over the past month. 52-week high ₹223.42, 52-week low ₹96.00.

Kronox Lab Sciences Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
173.45175.18171.70172.7926.86K (Cr)
169.02178.30165.05173.5786.95K (Cr)
170.36173.45163.85171.5351.27K (Cr)
172.55175.92169.00170.3639.39K (Cr)
171.11178.50170.00175.9271.65K (Cr)
171.00175.99170.00171.9665.58K (Cr)
174.81180.00166.01172.551.30L (Cr)
180.99184.45172.50174.971.04L (Cr)
185.00186.95179.10180.091.17L (Cr)
182.45189.00182.00184.6986.29K (Cr)

Kronox Lab Sciences Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
175.01191.80163.85172.79-1.27%
151.30223.42144.41177.34+17.21%
152.00175.00142.80151.30-0.46%
138.60159.98130.20149.96+8.20%
142.90145.80125.72138.87-2.82%
105.00146.9099.35140.62+33.92%
118.05118.9596.0097.02-17.81%
122.97132.59111.10119.83-2.55%
141.86142.20118.00122.53-13.63%
145.74147.20130.30139.74-4.12%
149.00154.95140.00142.88-4.11%
161.00161.99144.05148.29-7.89%

Returns & Performance

Excellent

Return on Equity (ROE)

26.82%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

34.75%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

30.10%

Average operating profit margin over 5 years

Dividend Yield

0.33%

Annual dividend as % of current share price

Kronox Lab Sciences Limited Valuation Check

Excellent

Price to Earnings (P/E)

22.18x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.95x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

74.21%

% shares held by company founders/management

Poor

FII Holding

0.04%

% shares held by foreign institutional investors

Poor

DII Holding

2.07%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Average

Profit Growth (Quarterly YoY)

16.31%

Net profit growth vs same quarter last year

Good

Revenue Growth (Quarterly YoY)

16.88%

Revenue growth vs same quarter last year

Average

Revenue Growth (5-Year CAGR)

10.14%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-54.98%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

23.29%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.01x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

328.22x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

69.80 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Kronox Lab Sciences Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of KRONOX across key market metrics for learning purposes.

Positive Indicators

12 factors identified

Strong Return on Equity (26.82%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (34.75%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (30.10%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 22.18 vs Industry: 31.95)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Strong Revenue Growth (16.88%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Strong Profit Growth Track Record (23.29% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.01)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (328.22x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Healthy Liquidity Position (Current Ratio: 7.60)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Strong Cash Generation (₹69.80 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (74.21%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

High Price-to-Book Ratio (5.52x)

Observation: Trading at significant premium to book value.

Analysis: High P/B ratios may indicate overvaluation relative to asset base.

Weak Earnings Growth (-54.98% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Limited Institutional Interest (FII+DII: 2.11%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

Kronox Lab Sciences Limited vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Kronox Lab Sciences Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
66/100
173
₹641.12
22.2
Average
26.82%
Excellent
34.75%
Excellent
0.0
Excellent
23.29%
Excellent
10.14%
Good
0.33%
65.3/100
1572
₹159998.16
60.4
Average
23.79%
Excellent
29.92%
Excellent
0.0
Excellent
16.70%
Excellent
14.89%
Good
0.73%
42.9/100
4755
₹52305.00
85.4
Average
7.65%
Poor
10.87%
Average
0.3
Excellent
36.34%
Excellent
13.52%
Good
0.07%
62.7/100
8776
₹45018.32
56.9
Average
20.11%
Excellent
21.48%
Excellent
0.3
Excellent
20.84%
Excellent
22.95%
Excellent
0.20%
32.8/100
1641
₹22385.97
28.6
Average
9.81%
Poor
11.31%
Average
0.3
Excellent
-6.63%
Poor
12.59%
Good
0.44%
36.3/100
1616
₹21439.79
90.9
Average
9.38%
Poor
12.78%
Average
0.2
Excellent
0.00%
58.2/100
6240
₹18370.56
23.1
Average
11.47%
Average
14.24%
Average
0.0
Excellent
54.89%
Excellent
10.95%
Good
0.49%
38.7/100
497
₹18009.05
33.9
Average
7.25%
Poor
8.86%
Poor
0.8
Good
-4.35%
Poor
12.96%
Good
0.20%
52.2/100
3749
₹16227.26
25.2
Average
0.00%
Poor
14.04%
Average
0.0
Excellent
7.67%
Good
9.35%
Good
0.68%
62.09999999999999/100
5170
₹15849.69
36.2
Average
16.82%
Good
21.91%
Excellent
0.0
Excellent
28.23%
Excellent
15.86%
Excellent
0.21%
33.3/100
1228
₹13980.53
79.8
Average
5.50%
Poor
9.10%
Poor
0.5
Good
19.33%
Excellent
23.88%
Excellent
0.06%

Kronox Lab Sciences Limited PE Ratio History

Historical price-to-earnings ratio for KRONOX — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20256.91₹139.7420.2x
FY 20245.75₹199.7434.7x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Kronox Lab Sciences Limited Dividend History

Annual cash dividends paid by KRONOX — dividend yield 0.33%

Financial YearDividends Paid (₹ Cr)
FY 20251.85 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Kronox Lab Sciences Limited Quarterly Performance

Latest quarterly metrics for KRONOX — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

16.88%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

16.31%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

10.14%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

23.29%

Compounded annual net profit growth over 5 years

Kronox Lab Sciences Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for KRONOX — calculated from daily price history

57RSI 14
Neutral — RSI 57

Momentum is balanced — neither overbought nor oversold.

SMA 50
164
▲ Price above SMA 50 — Short-term bullish
SMA 200
140
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
1310K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Kronox Lab Sciences Limited Financial Statements

Annual income statement, balance sheet and cash flow for Kronox Lab Sciences Limited (KRONOX) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Kronox Lab Sciences Limited

Loading latest quarterly results...

About KRONOX (Kronox Lab Sciences Limited)

Kronox Lab Science Ltd is a dynamic manufacturer specializing in a diverse array of high-purity specialty chemicals. The company operates with a core focus on crafting precision in...gredients that cater to a wide spectrum of industries. Their meticulous approach encompasses the production of inorganic and metallic chemicals alongside a comprehensive range of phosphates, all meticulously formulated to meet stringent quality standards. Kronox distinguishes itself through a commitment to innovation, continuously refining its processes to deliver chemicals that consistently exceed expectations. This dedication positions them as a trusted partner for businesses demanding excellence and reliability in their chemical inputs. The company’s product portfolio is strategically structured into three key categories, each addressing specific market demands. Their bulk reagents division provides essential chemicals with grades ranging from ACS to GR, catering to laboratory and research needs. The bulk ingredients segment focuses on supplying specialized compounds tailored for diverse applications, including oral care products, pharmaceuticals, and the ever-evolving food and nutraceutical industry. In addition to these, Kronox boasts a specialty chemicals division, where they synthesize complex compounds such as tartrates, citrates, and hypophosphites, showcasing their advanced capabilities in chemical synthesis. Each offering is supported by stringent quality control measures to ensure optimal purity and performance in its intended applications. Kronox Lab Science's global reach extends beyond India, solidifying its position as a prominent international supplier. They cultivate strong relationships with clients across various sectors, providing tailored solutions and unwavering support. By maintaining a keen awareness of evolving industry needs, Kronox proactively develops new products and refines existing ones to stay at the forefront of specialty chemical manufacturing. Their emphasis on sustainable practices and ethical sourcing underscores their commitment to responsible business operations, resonating with customers who value both quality and integrity. Kronox Lab Science is dedicated to advancing chemical science and delivering value to its customers worldwide.

Company Details

Symbol:KRONOX
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Mr. Jogindersingh Gianchand Jaswal
MD & Chairman
Mr. Ketan Ramani
Executive Whole-time Director
Mr. Pritesh Vinodchandra Ramani
Executive Whole-time Director

KRONOX Share Price: Frequently Asked Questions

What is the current share price of Kronox Lab Sciences Limited?

Kronox Lab Sciences Limited (KRONOX) trades at ₹172.79 on NSE and BSE. Market cap ₹641.12 (Cr). Educational data only.

What is the P/E ratio of Kronox Lab Sciences Limited?

Kronox Lab Sciences Limited has a P/E of 22.18x vs industry average 31.95x.

What is the Bull Run score for Kronox Lab Sciences Limited?

Kronox Lab Sciences Limited has a Bull Run score of 66/100 based on 25+ financial parameters.

Does Kronox Lab Sciences Limited pay dividends?

Kronox Lab Sciences Limited has a dividend yield of 0.33%. Past dividends don't guarantee future payments.

What is the ROE of Kronox Lab Sciences Limited?

Kronox Lab Sciences Limited has ROE of 26.82%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Kronox Lab Sciences Limited?

Kronox Lab Sciences Limited has debt-to-equity of 0.01.

Is Kronox Lab Sciences Limited a good investment?

Bull Run gives Kronox Lab Sciences Limited a score of 66/100. This is not investment advice — consult a SEBI-registered advisor.